Effects of dexamethasone on expressing MCP-1 mRNA in the rats With pulmonary fibrosis
- VernacularTitle:地塞米松对肺纤维化大鼠肺单核细胞趋化蛋白-1基因表达的影响
- Author:
Jun ZENG
;
Liechang SONG
;
Xingzhong JIN
;
Dan GUO
;
Jinming LIN
;
- Publication Type:Journal Article
- Keywords:
dexamethasone;
pulmonary fibrosis;
MCP 1
- From:
Chinese Pharmacological Bulletin
1987;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
AIM To study the effects of dexamethasone on expressing monocyte chemoattractant protein 1(MCP 1 ) mRNA in the rats with pulmonary fibrosis, elaborate the molecular mechanism of dexamethasone (Dxs) in pulmonary fibrosis therapy. METHODS The model of pulmonary fibrosis was established by instilling bleomycin intratracheally. After treating with Dxs ip , the levels of MCP 1 mRNA were determined by RT PCR. The histological changes were observed and the numbers of inflammatory cells were counted in optical microscopy field. RESULTS The accumulation of inflammatory cells decreased markedly, and the symptom of pulmonary fibrosis was alleviated. Furthermore, Dxs evidently inhibited the expression of MCP 1 mRNA in lung tissues with pulmonary fibrosis. CONCLUSION The molecular mechanism of Dxs in pulmonary fibrosis therapy was associated with inhibiting the expression of MCP 1 mRNA.
